Research ArticleCancer

Improved cancer immunotherapy by a CD25-mimobody conferring selectivity to human interleukin-2

See allHide authors and affiliations

Science Translational Medicine  30 Nov 2016:
Vol. 8, Issue 367, pp. 367ra166
DOI: 10.1126/scitranslmed.aag3187

Article Information

vol. 8 no. 367 367ra166

PubMed: 
Print ISSN: 
Online ISSN: 
History: 
  • Received for publication December 2, 2015
  • Resubmitted June 8, 2016
  • Accepted for publication September 8, 2016
  • .

Author Information

  1. Natalia Arenas-Ramirez1,
  2. Chao Zou2,
  3. Simone Popp2,
  4. Daniel Zingg3,
  5. Barbara Brannetti2,
  6. Emmanuelle Wirth2,
  7. Thomas Calzascia2,
  8. Jiri Kovarik2,
  9. Lukas Sommer3,
  10. Gerhard Zenke2,
  11. Janine Woytschak1,
  12. Catherine H. Regnier2,
  13. Andreas Katopodis2 and
  14. Onur Boyman1,*
  1. 1Department of Immunology, University Hospital Zurich, University of Zurich, CH-8091 Zurich, Switzerland.
  2. 2Novartis Institutes for Biomedical Research, Novartis Pharma AG, CH-4002 Basel, Switzerland.
  3. 3Stem Cell Biology, Institute of Anatomy, University of Zurich, CH-8057 Zurich, Switzerland.
  1. *Corresponding author. Email: onur.boyman{at}uzh.ch

Altmetric

Article usage

Article usage: November 2016 to November 2019

AbstractFullPdf
Nov 2016164188174
Dec 20166347351764
Jan 201777169133
Feb 201745633105
Mar 20172782078
Apr 20172213271
May 20172091966
Jun 20171491136
Jul 20171811638
Aug 20171532950
Sep 20171521849
Oct 20171571130
Nov 20171661419
Dec 20172453335
Jan 20182492038
Feb 20181591630
Mar 20181402441
Apr 20181473248
May 20181411837
Jun 20181212220
Jul 20181011721
Aug 2018612935
Sep 2018752133
Oct 2018733561
Nov 20181174940
Dec 2018682917
Jan 2019702531
Feb 2019953567
Mar 20191005363
Apr 2019652835
May 2019511825
Jun 2019621928
Jul 2019592534
Aug 2019482830
Sep 2019452721
Oct 2019773834
Nov 2019301525